Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With "Refractory Hypothyroidism"

Area of Science:

• Endocrinology
• Internal Medicine

Background:

• Hypothyroidism is common, with oral levothyroxine as the standard treatment.
• Over 15% of patients on levothyroxine do not reach target thyroid-stimulating hormone (TSH) levels.
• Refractory hypothyroidism can stem from malabsorption, increased thyroxine metabolism, or nonadherence.

Purpose of the Study:

• To evaluate the utility of a levothyroxine absorption test in patients with refractory hypothyroidism.
• To differentiate true malabsorption from nonadherence or pseudo-malabsorption.
• To assess the tolerability and effectiveness of the levothyroxine absorption test.

Main Methods:

• 166 levothyroxine absorption tests were performed in 143 hypothyroid patients.
• Patients with persistently high TSH levels despite oral levothyroxine treatment were included.
• Blood samples were collected for 24 hours after oral levothyroxine intake to measure total and free T4 levels.

Main Results:

• Refractory hypothyroidism was associated with gastritis, H. pylori infection, drug interactions, nonadherence, celiac disease, and bariatric surgery.
• Oral levothyroxine intake led to significant increases in total and free T4 levels within 4-6 hours.
• The levothyroxine absorption test was well-tolerated, with no reported cardiovascular adverse events.

Conclusions:

• The levothyroxine absorption test is a valuable tool for diagnosing the cause of refractory hypothyroidism.
• Evaluating T4 levels over a 4-6 hour period after levothyroxine intake can confirm absorption.
• This test is safe and effective in differentiating causes of treatment failure in hypothyroidism.